An exploratory single-arm study of the preventive effect of Nobelzin on the development of severe oral mucositis during radiation chemotherapy in oral cancer

Yanamoto Souichi0 个研究点目标入组 20 人开始时间: 2023年8月10日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Age: 18 to 90 years of age at the time of consent
•2. Patients who have obtained written consent from the individual or a proxy who is deemed able to represent the individual's wishes and interests.
•3. Patients with stage 2 or higher oral cancer who are scheduled to receive radiation chemotherapy (chemotherapy should be cisplatin or cetuximab)
•4. Patients with serum zinc concentration below the reference level (80 microgram/dL)
•5. Patients without oral mucositis at 2 weeks prior to the start of radiation chemotherapy

•1. Patients who are allergic or hypersensitive to any of the drugs in this study
•2. Patients who are using concomitant medications that should not be used in combination with the drugs in this study
•3. Patients who have difficulty in receiving cisplatin 80 mg/m2 in the case of cisplatin administration
•4. Patients who are judged by the investigator to be inappropriate as research subjects
•5. Patients participating in other clinical studies

发起方

Yanamoto Souichi